NCT06082271View on ClinicalTrials.gov

Comparative, Randomized Study on the Anti-inflammatory and Regenerative Efficacy of a New Medical Device (DM) Based on Hydrolyzed Collagen Peptides in Patients With Femoro-acetabular Impingement Undergoing Hip Arthroscopy

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 28, 2021

Primary Completion Date

November 30, 2023

Study Completion Date

December 20, 2023

Conditions
Femoroacetabular ImpingementHip ArthroscopyHip OsteoarthritisHydrolyzed Collagen Peptides
Interventions
DEVICE

Class III medical Hydrolyzed Collagen Peptides PEP-52 (Peptys)

Anti-inflammatory and regenerative effect, 5 mg/ml

DRUG

Cortisone

DEPO-MEDROL 40 mg/ml + 1 cc di NAROPINA 0,75% 7,5 mg/ml

Trial Locations (1)

40136

Istituto Ortopedico Rizzoli, Bologna

All Listed Sponsors
collaborator

Eleonora Olivotto

UNKNOWN

lead

Istituto Ortopedico Rizzoli

OTHER